Family Intervention for Black Teens With Type 1 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-14
SponsorWayne State University
About this trial
The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).
Eligibility criteria
Qualifiers
Age: 10 years, 0 months - 14 years, 11 months
Diagnosed with Type 1 diabetes
Diagnosed for at least 6 months
Black
Disqualifiers
Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality)
Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis)
Inability to speak or read English
Child is in out-of-home placement
Trial design
Treatments tested in this trial
- The 3Ms 2.0 Intervention
- Educational Attention Control (EAC)
Treatment groups
216 Participants
are divided into 2 treatment groupsSponsors and collaborators
Wayne State University
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Source ClinicalTrials.gov